The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug and Gene Delivery Devices Market Research Report 2024

Global Drug and Gene Delivery Devices Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1889749

No of Pages : 116

Ask Your Query
Synopsis
Drug And Gene Delivery Devices provides a new treatment method, become the main treatment of the global market.
The global Drug and Gene Delivery Devices market was valued at US$ 122060 million in 2023 and is anticipated to reach US$ 627450 million by 2030, witnessing a CAGR of 25.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Drug and Gene Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug and Gene Delivery Devices.
Report Scope
The Drug and Gene Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug and Gene Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug and Gene Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
F. Hoffmann-La Roche
Johnson and Johnson
Novartis
Bayer
Becton
Dickinson
Uniqure
SiBiono Gene
Epeius Biotechnologies
Shanghai Sunway Biotech
Human Stem Cells
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Chiesi
Phillips-Medisize
Segment by Type
Oral
Inhalation
Injectable
Others
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug and Gene Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug and Gene Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Drug and Gene Delivery Devices Market Overview
1.1 Product Overview and Scope of Drug and Gene Delivery Devices
1.2 Drug and Gene Delivery Devices Segment by Type
1.2.1 Global Drug and Gene Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Inhalation
1.2.4 Injectable
1.2.5 Others
1.3 Drug and Gene Delivery Devices Segment by Application
1.3.1 Global Drug and Gene Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global Drug and Gene Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Drug and Gene Delivery Devices Revenue 2019-2030
1.4.2 Global Drug and Gene Delivery Devices Sales 2019-2030
1.4.3 Global Drug and Gene Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug and Gene Delivery Devices Market Competition by Manufacturers
2.1 Global Drug and Gene Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug and Gene Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug and Gene Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Drug and Gene Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug and Gene Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug and Gene Delivery Devices, Product Type & Application
2.7 Drug and Gene Delivery Devices Market Competitive Situation and Trends
2.7.1 Drug and Gene Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug and Gene Delivery Devices Players Market Share by Revenue
2.7.3 Global Drug and Gene Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug and Gene Delivery Devices Retrospective Market Scenario by Region
3.1 Global Drug and Gene Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug and Gene Delivery Devices Global Drug and Gene Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Drug and Gene Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Drug and Gene Delivery Devices Sales by Region: 2025-2030
3.3 Global Drug and Gene Delivery Devices Global Drug and Gene Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Drug and Gene Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Drug and Gene Delivery Devices Revenue by Region: 2025-2030
3.4 North America Drug and Gene Delivery Devices Market Facts & Figures by Country
3.4.1 North America Drug and Gene Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug and Gene Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Drug and Gene Delivery Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug and Gene Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Drug and Gene Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug and Gene Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Drug and Gene Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug and Gene Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Drug and Gene Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug and Gene Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug and Gene Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug and Gene Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Drug and Gene Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug and Gene Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Drug and Gene Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug and Gene Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug and Gene Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug and Gene Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug and Gene Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug and Gene Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Drug and Gene Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Drug and Gene Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Drug and Gene Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Drug and Gene Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Drug and Gene Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Drug and Gene Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Drug and Gene Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Drug and Gene Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug and Gene Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Drug and Gene Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Drug and Gene Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Drug and Gene Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Drug and Gene Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Drug and Gene Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Drug and Gene Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Drug and Gene Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Drug and Gene Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Drug and Gene Delivery Devices Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffmann-La Roche Drug and Gene Delivery Devices Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson and Johnson Drug and Gene Delivery Devices Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Drug and Gene Delivery Devices Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Drug and Gene Delivery Devices Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Becton
6.6.1 Becton Corporation Information
6.6.2 Becton Description and Business Overview
6.6.3 Becton Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Becton Drug and Gene Delivery Devices Product Portfolio
6.6.5 Becton Recent Developments/Updates
6.7 Dickinson
6.6.1 Dickinson Corporation Information
6.6.2 Dickinson Description and Business Overview
6.6.3 Dickinson Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dickinson Drug and Gene Delivery Devices Product Portfolio
6.7.5 Dickinson Recent Developments/Updates
6.8 Uniqure
6.8.1 Uniqure Corporation Information
6.8.2 Uniqure Description and Business Overview
6.8.3 Uniqure Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Uniqure Drug and Gene Delivery Devices Product Portfolio
6.8.5 Uniqure Recent Developments/Updates
6.9 SiBiono Gene
6.9.1 SiBiono Gene Corporation Information
6.9.2 SiBiono Gene Description and Business Overview
6.9.3 SiBiono Gene Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SiBiono Gene Drug and Gene Delivery Devices Product Portfolio
6.9.5 SiBiono Gene Recent Developments/Updates
6.10 Epeius Biotechnologies
6.10.1 Epeius Biotechnologies Corporation Information
6.10.2 Epeius Biotechnologies Description and Business Overview
6.10.3 Epeius Biotechnologies Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Epeius Biotechnologies Drug and Gene Delivery Devices Product Portfolio
6.10.5 Epeius Biotechnologies Recent Developments/Updates
6.11 Shanghai Sunway Biotech
6.11.1 Shanghai Sunway Biotech Corporation Information
6.11.2 Shanghai Sunway Biotech Drug and Gene Delivery Devices Description and Business Overview
6.11.3 Shanghai Sunway Biotech Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Sunway Biotech Drug and Gene Delivery Devices Product Portfolio
6.11.5 Shanghai Sunway Biotech Recent Developments/Updates
6.12 Human Stem Cells
6.12.1 Human Stem Cells Corporation Information
6.12.2 Human Stem Cells Drug and Gene Delivery Devices Description and Business Overview
6.12.3 Human Stem Cells Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Human Stem Cells Drug and Gene Delivery Devices Product Portfolio
6.12.5 Human Stem Cells Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Corporation Information
6.13.2 Cipla Drug and Gene Delivery Devices Description and Business Overview
6.13.3 Cipla Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cipla Drug and Gene Delivery Devices Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Baxter International
6.14.1 Baxter International Corporation Information
6.14.2 Baxter International Drug and Gene Delivery Devices Description and Business Overview
6.14.3 Baxter International Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Baxter International Drug and Gene Delivery Devices Product Portfolio
6.14.5 Baxter International Recent Developments/Updates
6.15 Nipro Corporation
6.15.1 Nipro Corporation Corporation Information
6.15.2 Nipro Corporation Drug and Gene Delivery Devices Description and Business Overview
6.15.3 Nipro Corporation Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nipro Corporation Drug and Gene Delivery Devices Product Portfolio
6.15.5 Nipro Corporation Recent Developments/Updates
6.16 Roche
6.16.1 Roche Corporation Information
6.16.2 Roche Drug and Gene Delivery Devices Description and Business Overview
6.16.3 Roche Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Roche Drug and Gene Delivery Devices Product Portfolio
6.16.5 Roche Recent Developments/Updates
6.17 Boehringer Ingelheim
6.17.1 Boehringer Ingelheim Corporation Information
6.17.2 Boehringer Ingelheim Drug and Gene Delivery Devices Description and Business Overview
6.17.3 Boehringer Ingelheim Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Boehringer Ingelheim Drug and Gene Delivery Devices Product Portfolio
6.17.5 Boehringer Ingelheim Recent Developments/Updates
6.18 Allergan
6.18.1 Allergan Corporation Information
6.18.2 Allergan Drug and Gene Delivery Devices Description and Business Overview
6.18.3 Allergan Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Allergan Drug and Gene Delivery Devices Product Portfolio
6.18.5 Allergan Recent Developments/Updates
6.19 3M
6.19.1 3M Corporation Information
6.19.2 3M Drug and Gene Delivery Devices Description and Business Overview
6.19.3 3M Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.19.4 3M Drug and Gene Delivery Devices Product Portfolio
6.19.5 3M Recent Developments/Updates
6.20 BD
6.20.1 BD Corporation Information
6.20.2 BD Drug and Gene Delivery Devices Description and Business Overview
6.20.3 BD Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.20.4 BD Drug and Gene Delivery Devices Product Portfolio
6.20.5 BD Recent Developments/Updates
6.21 Catalent
6.21.1 Catalent Corporation Information
6.21.2 Catalent Drug and Gene Delivery Devices Description and Business Overview
6.21.3 Catalent Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Catalent Drug and Gene Delivery Devices Product Portfolio
6.21.5 Catalent Recent Developments/Updates
6.22 Valeant Pharmaceuticals
6.22.1 Valeant Pharmaceuticals Corporation Information
6.22.2 Valeant Pharmaceuticals Drug and Gene Delivery Devices Description and Business Overview
6.22.3 Valeant Pharmaceuticals Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Valeant Pharmaceuticals Drug and Gene Delivery Devices Product Portfolio
6.22.5 Valeant Pharmaceuticals Recent Developments/Updates
6.23 Chiesi
6.23.1 Chiesi Corporation Information
6.23.2 Chiesi Drug and Gene Delivery Devices Description and Business Overview
6.23.3 Chiesi Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Chiesi Drug and Gene Delivery Devices Product Portfolio
6.23.5 Chiesi Recent Developments/Updates
6.24 Phillips-Medisize
6.24.1 Phillips-Medisize Corporation Information
6.24.2 Phillips-Medisize Drug and Gene Delivery Devices Description and Business Overview
6.24.3 Phillips-Medisize Drug and Gene Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Phillips-Medisize Drug and Gene Delivery Devices Product Portfolio
6.24.5 Phillips-Medisize Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug and Gene Delivery Devices Industry Chain Analysis
7.2 Drug and Gene Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug and Gene Delivery Devices Production Mode & Process
7.4 Drug and Gene Delivery Devices Sales and Marketing
7.4.1 Drug and Gene Delivery Devices Sales Channels
7.4.2 Drug and Gene Delivery Devices Distributors
7.5 Drug and Gene Delivery Devices Customers
8 Drug and Gene Delivery Devices Market Dynamics
8.1 Drug and Gene Delivery Devices Industry Trends
8.2 Drug and Gene Delivery Devices Market Drivers
8.3 Drug and Gene Delivery Devices Market Challenges
8.4 Drug and Gene Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock